ClearOne is trading 11.37% up at $4.70 as investors continue reacting to Vivani Medical’s September 16, 2026 update that it expects pricing and closing of its Cortigent merger with ClearOne in October.
- Cortigent would become ClearOne’s wholly owned subsidiary.
- Vivani would acquire 12.5 million ClearOne shares.
- The company-specific merger catalyst is the clearest explanation for the sharp move.